NEW YORK, November 12, 2018 /PRNewswire/ --
Recent referendums on cannabis legalization initiatives have proved once again that the social consensus regarding marijuana
use is changing. Three of the four states in which such initiatives were on the ballot have voted in favor of legalization.
According to information recently provided by New Frontier Data, the legalization of medical cannabis in Utah and Missouri and legalization of adult-use cannabis in Michigan will help create new markets that are projected to account for more than USD
1.2 Billion in additional sales for a combined total of USD 2.1 Billion in total legal sales
by 2025. This increase will create more than 30,000 additional cannabis jobs over the same period. CLS Holdings, USA Inc. (OTC: CLSH), Tilray, Inc. (NASDAQ: TLRY), Aphria Inc. (NYSE: APHA), The Green Organic Dutchman
Holdings Ltd. (OTC: TGODF), MariMed Inc. (OTC: MRMD)
According to another report from cannabis staffing agency Vangst, the number of cannabis jobs and their average salary has
increased rapidly in recent years due to the increasing legalization of cannabis. The growth in cannabis job listing had surged
690% since the beginning of 2017, while the average salary of cannabis positions increased by 16.1% between 2017 and 2018.
"Cannabis legalization in some form has occurred in nearly 60% of the United State's and based on our research, legal retail
sales revenues are currently estimated to be $10.3 billion in 2018; we now project the market to
grow to more than $25 billion while supporting more than 642,000 jobs by 2025," said Giadha Aguirre
de Carcer, Founder and CEO of New Frontier Data.
CLS Holdings, USA Inc. (OTCQB: CLSH) just earlier this
morning announced breaking cannabis news that, "Meet the City Trees Team at Booth #3913 City Trees Products Available in 35
Nevada Dispensaries City Trees Considers Expansion Beyond Nevada, its Nevada wholesale brand,
City Trees, will be an exhibitor at the 2018 Marijuana Business Convention "MJ Biz Con" in Las
Vegas from November 14 to the 16. CLSH also announced the City Trees product line is now
being sold in over 35 dispensaries throughout Nevada and it is considering expanding the brand
beyond the Nevada market.
Visitors to the booth at MJ Biz Con will have the opportunity to meet the City Trees team and learn about the product line.
CLS Nevada, Inc. Chief Operating Officer Don Decatur commented,
"We are excited to showcase the City Trees product line at MJ Biz Con this year as we consider expanding the brand beyond the
Nevada market." MJ Biz Con attendees will find the City Trees team at booth #3913, adjacent to
the conference registration area.
City Trees added 5 new wholesale customers in the last 30 days. Its line of disposable vapes, cartridges, tinctures, and
capsules can now be purchased in over half of the dispensaries in Nevada. Decatur explained the
growth, "Our dedication to premium quality, competitive pricing, and the team's focus on excellent customer service all
contribute to the continued success of City Trees."
About Oasis Cannabis (http://oasiscannabis.com) - Oasis Cannabis
has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in
Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its
location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination
with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In August 2017, the company commenced wholesale offerings of
cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and
cannabis-infused products. An expansion of its cultivation and production facility is currently underway and is expected to be
completed during the fourth quarter of 2018.
About CLS Holdings USA, Inc. - CLS Holdings USA, Inc.
(CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an
integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and
plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary
method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of
quality and consistency. The Company's business model includes licensing operations, processing operations, processing
facilities, sale of products, brand creation and consulting services. For additional information, please visit: http://www.clsholdingsinc.com"
Tilray, Inc. (NASDAQ: TLRY) is a global pioneer in the research, cultivation, production and distribution of medical
cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents. Tilray,
Inc. recently announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology
SpA. The acquisition will allow Tilray to import, produce and distribute Tilray branded medical cannabis products in Chile and to create a hub to distribute Tilray products throughout Latin
America. Tilray previously announced a partnership with Alef in February 2017 to import and
distribute Tilray products in Chile and Brazil. Alef is
currently licensed by the Chilean government to commercially produce medical cannabis and is developing a state-of-the-art
facility to domestically produce and process medical cannabis products. Chilean law permits patients to access medical cannabis
products under the supervision of a recommending physician. "Today's announcement marks another milestone for Tilray as we expand
our global footprint and solidify our presence in Latin America by officially welcoming Alef to
the Tilray team," said Brendan Kennedy, President and Chief Executive Officer of Tilray. "The
Chilean government has been a pioneer legitimizing and regulating medical cannabis in Latin
America, and we are thrilled to be investing in one of the region's most exciting markets for biopharmaceutical
development."
Aphria Inc. (NYSE: APHA) is a leading global cannabis company driven by an unrelenting commitment to our people,
product quality and innovation. Aphria Inc. recently announced its proposed acquisition of CC Pharma GmbH, a leading distributor
of pharmaceutical products to more than 13,000 pharmacies in Germany. The transaction, when
closed, will strengthen the Company's end-to-end medical cannabis operations and infrastructure in Germany, a key market in Aphria's international expansion. It is anticipated that the transaction will close
in January 2019. "This acquisition strengthens our foothold in Germany, one of the most highly sought-after medical cannabis markets in the world," said Vic Neufeld, Chief Executive Officer of Aphria. "CC Pharma is cash-flow positive and has significant
experience with regulatory requirements and international logistics. It will be a strong addition to Aphria's presence in
Germany, providing deeper access to the important pharmacist channel and advancing our ambitious
global growth strategy."
The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF) is a research & development company licensed under the
Access to Cannabis for Medical Purposes Regulations to cultivate medical cannabis. The Green Organic Dutchman Holdings Ltd.
recently announced the launch of its premium, certified organic cannabis brand. This preeminent launch coincides with Canadian
Organic Week, the largest annual celebration of organic food, farming and products across the country. This is a pivotal step for
the Company in becoming the largest, organic cannabis brand in the world. "Organically certified cannabis is preferred by
Canadian consumers, in both medical and recreational markets," said Andrew Pollock, TGOD's Vice
President of Marketing. "Cannabis consumers value the safety, medical efficacy and natural terpene profiles that organic cannabis
provides. Our mission is Making Life Better, and our organic cannabis products deliver on that promise. TGOD is an organic
community that consumers will be proud to join," continued Pollock.
MariMed Inc. (OTCQB: MRMD) recently announced that it has finalized the acquisition of BSC Group, a highly respected
cannabis firm headquartered in New Jersey that over the last three years has been engaged in
competitive licensing, consulting and operations management across the country. BSC founders and managing partners, Brian Staffa
and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise,
resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial
cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied
sciences. "Our team has worked with BSC Group on various projects in the past, and their laser focus made them an ideal partner
to help fuel MariMed's forward momentum," said MariMed Chief Executive Officer Bob Fireman. "We
are excited to bring on Amber and Brian, who have seasoned cannabis operations, corporate strategy, branding and marketing
expertise. An organization is only as good as the people in it. The Staffas share our vision and work ethic and will be a great
addition to our team."
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For cls holdings usa inc. financial and corporate news dissemination,
FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either
a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof.
The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near
the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for
financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or
continue to post information about any companies the information contained herein is not intended to be used as the basis for
investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is
not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for
any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other
materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of
their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance,
and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound
by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com.
For further information:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com